2018
DOI: 10.1007/s11307-018-1230-y
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice

Abstract: Purpose: Multidrug resistance-associated proteins (MRPs) mediate the hepatobiliary and renal excretion of many drugs and drug conjugates. The positron emission tomography (PET) tracer 6-bromo-7-[11 C]methylpurine is rapidly converted in tissues by glutathione-S-transferases into its glutathione conjugate, and has been used to measure the activity of Abcc1 in the brain and the lungs of mice. Aim of this work was to investigate if the activity of MRPs in excretory organs can be measured with 6-bromo-7-[ 11 C]met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
48
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 16 publications
(51 citation statements)
references
References 39 publications
3
48
0
Order By: Relevance
“…Mice were injected intraperitoneally under anesthesia 30 minutes before the start of the PET scan either with vehicle solution (PBS; wild-type: n 5 6, hABCC1 flx/flx : n 5 5, hABCC1 2/2 : n 5 4, Abcc1 2/2 : n 5 6), or with MK571 (5-(3-(2-(7-Chloroquinolin-2-yl)ethenyl)phenyl)-8dimethylcarbamyl-4,6-dithiaoctanoic acid) (Chemical Abstracts Service Number: 115103-85-0, 300 mg/kg; hABCC1 flx/flx : n 5 3, wildtype: n 5 7). Subsequently, 6-bromo-7-[ 11 C]methylpurine (32.85 6 7.34 MBq; 0.1 ml; 1.26 6 14.80 nmol), which had been synthesized as described previously (Zoufal et al, 2019), was administered as an intravenous bolus via the lateral tail vein and a 90-minute dynamic PET scan was initiated at the start of radiotracer injection (timing window 6 nanoseconds; energy window of 250-750 keV).…”
Section: Positron Emission Tomography Imagingmentioning
confidence: 99%
See 3 more Smart Citations
“…Mice were injected intraperitoneally under anesthesia 30 minutes before the start of the PET scan either with vehicle solution (PBS; wild-type: n 5 6, hABCC1 flx/flx : n 5 5, hABCC1 2/2 : n 5 4, Abcc1 2/2 : n 5 6), or with MK571 (5-(3-(2-(7-Chloroquinolin-2-yl)ethenyl)phenyl)-8dimethylcarbamyl-4,6-dithiaoctanoic acid) (Chemical Abstracts Service Number: 115103-85-0, 300 mg/kg; hABCC1 flx/flx : n 5 3, wildtype: n 5 7). Subsequently, 6-bromo-7-[ 11 C]methylpurine (32.85 6 7.34 MBq; 0.1 ml; 1.26 6 14.80 nmol), which had been synthesized as described previously (Zoufal et al, 2019), was administered as an intravenous bolus via the lateral tail vein and a 90-minute dynamic PET scan was initiated at the start of radiotracer injection (timing window 6 nanoseconds; energy window of 250-750 keV).…”
Section: Positron Emission Tomography Imagingmentioning
confidence: 99%
“…Using AMIDE software (Loening and Gambhir, 2003), whole brain and right lung were manually outlined on the PET images to derive concentration-time curves expressed in units of standardized uptake value [standardized uptake value 5 (radioactivity per gram/injected radioactivity) Â body weight]. From the logtransformed concentration-time curves, the elimination slope of radioactivity washout from tissue [k elimination, brain or k elimination, lung , (hour 21 )] was determined by linear regression analysis of data from 17.5 to 80 minutes after radiotracer injection (Zoufal et al, 2019).…”
Section: Positron Emission Tomography Imagingmentioning
confidence: 99%
See 2 more Smart Citations
“…C-BMP was synthesized as described before(15) in a decay-corrected radiochemical yield of 4.7±1.1% (based on 11 C-methane) with a radiochemical purity >98% and a molar activity at the end of synthesis of 129±74 GBq/μmol (n=24). For i.v.…”
mentioning
confidence: 99%